Gene Therapy CDMO Services
Continuity and Ingenuity to Meet Your pDNA Needs
At Cytovance Biologics, we are proud to empower gene therapies making significant impacts in medicine through our high-quality plasmid DNA (pDNA) offering and analytical services. Leveraging our decades of experience in over 200 biologics, we have developed our Integrated Platform for Plasmid DNA manufacturing that can be used in viral vector production, mRNA vaccines, and direct as an API. Our platformed approach to pDNA provides the ultimate flexibility and minimal turnaround times to our partners through multiple single-use fermentation technologies, fully integrated processing, and in-house product release testing. From research to clinical manufacturing, our culture of ingenuity and team of scientific, manufacturing, and regulatory experts unite to ensure a cost-effective and steady supply of high-quality pDNA for your program.
Stability indicating assays for pDNA and more.
Ingenuity, On Demand
Thought Leadership from Team Cytovance
pDNA Manufacturing: An Optimized Platform Process
Regulatory Strategies for Gene Therapy Product Development
An Integrated Single-Use Platform for Manufacturing Plasmid DNA (pDNA)
The Power of Partnership
"Demand for therapeutic biologics in the gene therapy space is increasing rapidly and requires manufacturing capacity and expertise. Our collaboration with Cytovance Biologics demonstrates our commitment to cell and gene therapy biomanufacturers…in unlocking the potential these therapies hold for patients around the globe."
— Dr. Ger Brophy, Executive Vice President, Biopharma Production